nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
2024 American Thoracic Society International Conference
|
Venkatesan, Priya |
|
|
12 |
8 |
p. 586-588 |
artikel |
2 |
Azithromycin for the prevention of chronic lung disease of prematurity: not a silver bullet
|
Razak, Abdul |
|
|
12 |
8 |
p. 579-580 |
artikel |
3 |
Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial
|
Lowe, John |
|
|
12 |
8 |
p. 608-618 |
artikel |
4 |
Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials
|
Thomas, Brady |
|
|
12 |
8 |
p. e43 |
artikel |
5 |
Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials – Authors' reply
|
Lowe, John |
|
|
12 |
8 |
p. e44 |
artikel |
6 |
Concerning the use of aminoglycosides in ventilator-associated pneumonia
|
de Jong, Simone Y M |
|
|
12 |
8 |
p. e45 |
artikel |
7 |
Concerning the use of aminoglycosides in ventilator-associated pneumonia – Authors' reply
|
Chhabra, Srishti |
|
|
12 |
8 |
p. e46 |
artikel |
8 |
Correction to Lancet Respir Med 2024; 12: 642–54
|
|
|
|
12 |
8 |
p. e51 |
artikel |
9 |
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies
|
Martinez, Leonardo |
|
|
12 |
8 |
p. 633-641 |
artikel |
10 |
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
|
Li, Ziming |
|
|
12 |
8 |
p. 589-598 |
artikel |
11 |
Household air pollution: a neglected threat
|
The Lancet Respiratory Medicine, |
|
|
12 |
8 |
p. 575 |
artikel |
12 |
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial
|
Mart, Matthew F |
|
|
12 |
8 |
p. 599-607 |
artikel |
13 |
Moving forward in IPF: lessons learned from clinical trials
|
Raghu, Ganesh |
|
|
12 |
8 |
p. 583-585 |
artikel |
14 |
Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial
|
Little, Paul |
|
|
12 |
8 |
p. 619-632 |
artikel |
15 |
Overcoming barriers to scaling up tuberculosis preventive treatment for household contacts
|
Churchyard, Gavin |
|
|
12 |
8 |
p. 582-583 |
artikel |
16 |
Potential for personalised and biomarker-guided COPD self-treatment approaches
|
Lenferink, Anke |
|
|
12 |
8 |
p. e48-e49 |
artikel |
17 |
Tackling KRAS G12C-mutated non-small-cell lung cancer: iteration and exploration
|
Luo, Jia |
|
|
12 |
8 |
p. 576-577 |
artikel |
18 |
The recent explosion in snortable energy powder consumption
|
Pourchez, Jérémie |
|
|
12 |
8 |
p. e47 |
artikel |
19 |
Treating acute respiratory illness: the need to be proactive
|
Giamarellos-Bourboulis, Evangelos J |
|
|
12 |
8 |
p. 580-581 |
artikel |
20 |
Treatment effects on functional outcomes in trials with severely ill patients
|
Ng, Edmond S W |
|
|
12 |
8 |
p. 577-578 |
artikel |
21 |
When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unit
|
Lee, Kevin G |
|
|
12 |
8 |
p. 642-654 |
artikel |
22 |
Whooping cough cases rising
|
Venkatesan, Priya |
|
|
12 |
8 |
p. e50 |
artikel |